InvestorsHub Logo
Followers 1
Posts 35
Boards Moderated 0
Alias Born 02/06/2017

Re: Rymankoly post# 5934

Thursday, 03/16/2017 1:51:52 PM

Thursday, March 16, 2017 1:51:52 PM

Post# of 8169
Agree with you - high risk here, so people will want to get out...

Just opening the Ph2 is not necessarily a value driver for me. They had a Ph2 before and that didn't help them much.
I am wondering how they will be enrolling and dosing patients this month (acc'd to their milestones) for the Ph2 while they are still evaluating dose levels in the Ph1. Opening cohort 4 was spun as great news, but in reality it may be pushing out there Ph2 now as they have uncertainty about the starting dose level.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CLRB News